Cargando…

Comparative In Vitro Study of Various α(2)-Adrenoreceptor Agonist Drugs for Ticagrelor Reversal

Ticagrelor, an antiplatelet adenosine diphosphate (ADP)-P2Y(12) receptor antagonist, increases the risk of bleeding. Its management is challenging because platelet transfusion is ineffective and no specific antidote is currently available. Epinephrine, a vasopressor catecholamine prescribed during s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porta Bonete, Guillaume, Godier, Anne, Gaussem, Pascale, Belleville-Rolland, Tiphaine, Leuci, Alexandre, Poirault-Chassac, Sonia, Bachelot-Loza, Christilla, Martin, Anne-Céline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141185/ https://www.ncbi.nlm.nih.gov/pubmed/32188130 http://dx.doi.org/10.3390/jcm9030809

Ejemplares similares

Human endoglin as a potential new partner involved in platelet–endothelium interactions
por: Rossi, Elisa, et al.
Publicado: (2017)

Endoglin Is an Endothelial Housekeeper against Inflammation: Insight in ECFC-Related Permeability through LIMK/Cofilin Pathway
por: Rossi, Elisa, et al.
Publicado: (2021)

Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report
por: Godier, Anne, et al.
Publicado: (2018)

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
por: Jourdi, Georges, et al.
Publicado: (2021)

P2Y(12) Inhibition beyond Thrombosis: Effects on Inflammation
por: Mansour, Alexandre, et al.
Publicado: (2020)

Platelet‐mapping assay for monitoring antiplatelet therapy during mechanical circulatory support in children: A retrospective observational study
por: Giorni, Chiara, et al.
Publicado: (2017)

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
por: Mansour, Alexandre, et al.
Publicado: (2020)

Impact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery
por: Le Manach, Yannick, et al.
Publicado: (2014)

No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro
por: Gaussem, Pascale, et al.
Publicado: (2009)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
por: Jourdi, Georges, et al.
Publicado: (2022)

Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms
por: Larréché, Sébastien, et al.
Publicado: (2023)

Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches
por: Jourdi, Georges, et al.
Publicado: (2022)

Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly?
por: Pontis, Adeline, et al.
Publicado: (2022)

Indacaterol, A Novel Once Daily Inhaled β2-Adrenoreceptor Agonist
por: Roig, Jorge, et al.
Publicado: (2009)

Mirabegron – a selective β3-adrenoreceptor agonist for the treatment of overactive bladder
por: Bhide, Alka A, et al.
Publicado: (2012)

Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy
por: Yang, Chongzhe, et al.
Publicado: (2022)

MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression
por: Vanhoutte, Laetitia, et al.
Publicado: (2017)

Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study
por: Gendron, Nicolas, et al.
Publicado: (2019)

β-Adrenoreceptor agonists in the management of pain associated with renal colic: a systematic review
por: Tabner, Andrew John, et al.
Publicado: (2016)

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month
por: Eyraud, Daniel, et al.
Publicado: (2018)

ß-Adrenoreceptors in Human Cancers
por: Kraboth, Zoltan, et al.
Publicado: (2023)

The effects of novel α(2)-adrenoreceptor agonist dexmedetomidine on shivering in patients underwent caesarean section
por: Yu, Gaofeng, et al.
Publicado: (2019)

Mirabegron, a β3‑adrenoreceptor agonist, regulates right and left atrial arrhythmogenesis differently
por: Chan, Chao-Shun, et al.
Publicado: (2022)

Another “String to the Bow” of PJ34, a Potent Poly(ADP-Ribose)Polymerase Inhibitor: An Antiplatelet Effect through P2Y(12) Antagonism?
por: Lechaftois, Marie, et al.
Publicado: (2014)

The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro
por: Anderson, Ronald, et al.
Publicado: (2014)

The use of β(2)-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines
por: Nino, Gustavo, et al.
Publicado: (2020)

Adrenoreceptors and nitric oxide in the cardiovascular system
por: Conti, Valeria, et al.
Publicado: (2013)

Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein
por: Patterson, Joseph R., et al.
Publicado: (2022)

Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β(2)-adrenoreceptor agonist (uLABA)
por: Bjermer, Leif, et al.
Publicado: (2015)

Inhalation of a Short-Acting β(2)-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects
por: Ali-Saleh, Mais, et al.
Publicado: (2016)

Clinical Utility of β(3)-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations
por: Krhut, Jan, et al.
Publicado: (2022)

Terminal Platelet Production is Regulated by Von Willebrand Factor
por: Poirault-Chassac, Sonia, et al.
Publicado: (2013)

Microfluidic model of the platelet-generating organ: beyond bone marrow biomimetics
por: Blin, Antoine, et al.
Publicado: (2016)

EPAC1 inhibition protects the heart from doxorubicin-induced toxicity
por: Mazevet, Marianne, et al.
Publicado: (2023)

Beta 3 Adrenoreceptor Agonist for the Management of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia: A Systematic Review
por: Kang, Tae Wook, et al.
Publicado: (2021)

Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
por: Omarjee, Loukman, et al.
Publicado: (2020)

Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes
por: Pietrzyk-Nivau, Audrey, et al.
Publicado: (2015)

Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells
por: Calvani, Maura, et al.
Publicado: (2019)

Effect of Beta 3 Adrenoreceptor Modulation on Patency of the Ductus Arteriosus
por: Pini, Alessandro, et al.
Publicado: (2020)

Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection
por: Martin, Anne-Céline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pm1ktq40e5sjj2j2tu0qqvfp3m